What one share of Guardant Health holds
We are a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. We are transforming patient care by providing critical insights into what drives disease through our advanced blood and tissue tests, real-world data and AI analytics.
Guardant Health’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $9.14 |
|---|---|
| Profit | −$3.50 |
| Capex (buildings and equipment) | $0.43 |
| Free cash flow | −$1.86 |
| Cash and investments | $7.88 |
| Debt | $11.25 |
| Book value | −$1.67 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $1.93 | −$3.53 | $0.14 | −$2.95 | — | $6.11 |
| 2017 | $3.96 | −$7.07 | $0.53 | −$6.27 | — | $25.94 |
| 2018 | $2.98 | −$2.80 | $0.66 | −$3.04 | — | — |
| 2019 | $2.37 | −$0.83 | $0.21 | −$0.73 | — | $8.47 |
| 2020 | $2.94 | −$2.60 | $0.37 | −$1.44 | — | $12.96 |
| 2021 | $3.69 | −$4.00 | $0.74 | −$2.80 | — | $6.34 |
| 2022 | $4.40 | −$6.41 | $0.76 | −$3.79 | — | $0.59 |
| 2023 | $5.04 | −$4.28 | $0.18 | −$3.08 | — | $1.30 |
| 2024 | $6.02 | −$3.56 | $0.29 | −$2.24 | — | −$1.13 |
| 2025 | $7.83 | −$3.32 | $0.39 | −$1.86 | — | −$0.76 |
Common questions about Guardant Health
How much does one share of Guardant Health earn?
Over the last 12 months, Guardant Health lost $3.50 for each share on $9.14 of sales.
Does Guardant Health pay a dividend?
Guardant Health didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Guardant Health’s book value per share?
Guardant Health’s book value is negative (−$1.67 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Guardant Health have?
Each share of Guardant Health has $7.88 of cash and investments and $11.25 of debt, as of June 30, 2026.
What is Guardant Health’s free cash flow per share?
−$1.86 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Guardant Health bought back shares?
Guardant Health’s share count rose about 860% from 2016 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.